SMO ClinPlusLTD Third Quarter 2024 Earnings EPS CN0.41
| AVXL Stock | USD 9.11 0.09 1.00% |
About 58% of all Anavex Life's institutional investors are looking to take a long position. The analysis of the overall investor sentiment regarding Anavex Life Sciences suggests that some traders are interested. Anavex Life's investing sentiment shows overall attitude of investors towards Anavex Life Sciences.
Anavex |
SMO ClinPlusLTD Third Quarter 2024 Results Key Financial Results Revenue CN199.3m up 2.0 percent from 3Q...
Read at simplywall.st
 |
Anavex Life Fundamental Analysis
We analyze Anavex Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anavex Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anavex Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Probability Of Bankruptcy
Probability Of Bankruptcy Comparative Analysis
Anavex Life is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
Anavex Life Sciences Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Anavex Life stock to make a market-neutral strategy. Peer analysis of Anavex Life could also be used in its relative valuation, which is a method of valuing Anavex Life by comparing valuation metrics with similar companies.
Peers
Anavex Life Related Equities
| RVPHW | Reviva Pharmaceuticals | 23.53 | ||||
| EYEN | Eyenovia | 19.05 | ||||
| RNAZ | Transcode Therapeutics | 11.76 | ||||
| MDGL | Madrigal Pharmaceuticals | 5.53 | ||||
| NVAX | Novavax | 5.35 | ||||
| KOD | Kodiak Sciences | 4.92 | ||||
| IOVA | Iovance Biotherapeutics | 3.76 | ||||
| INMB | INmune Bio | 2.31 | ||||
| EXEL | Exelixis | 2.24 | ||||
| VKTX | Viking Therapeutics | 1.86 | ||||
| TGTX | TG Therapeutics | 1.51 | ||||
| AXSM | Axsome Therapeutics | 0.50 | ||||
| BIVI | Biovie | 1.93 | ||||
| ANVS | Annovis Bio | 2.06 | ||||
| CGTX | Cognition Therapeutics | 2.27 | ||||
| BTAI | BioXcel Therapeutics | 10.53 | ||||
| SAVA | Cassava Sciences | 17.71 |
Check out Anavex Life Hype Analysis, Anavex Life Correlation and Anavex Life Performance. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.51) | Return On Assets (0.20) | Return On Equity (0.30) |
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.